BrainChip Holdings Ltd, a leading provider of Artificial Intelligence (AI) technology, announced a research collaboration with precision immunology company Biotome Pty Ltd. to develop highly accurate antibody tests for infections.
The Akida neuromorphic processor chip will be used to interpret sensor responses and to find out which responses are the most representative for antibodies that are protective. The objective of the Biotome research project is to create a handheld device that uses nanomaterial-based sensors in combination with the Akida chip that will give accurate results in seconds.
The Akida processor is an essential part of this development in its ability to learn new sensory data patterns instantly, and classify the results in milliseconds at power consumption in the microwatts range. This enables the use of advanced diagnostic equipment that operates on small batteries in even remote locations.
BrainChip’s Akida chip brings AI to the edge in a way that existing technologies are not capable. The solution is high-performance, small, ultra-low power and provides a wide array of capabilities. The Akida (NSoC) and intellectual property can be used in applications including Smart Home, Smart Health, Smart City and Smart Transportation. These applications include but are not limited to home automation and remote controls, industrial IoT, robotics, security cameras, sensors, unmanned aircraft, autonomous vehicles, medical instruments, object detection, sound detection, odour and taste detection, gesture control and cybersecurity. The Akida NSoC is designed for use as a stand-alone embedded processor or as a co-processor and includes interfaces for ADAS sensors, audio and video sensors, medical sensors and other IoT sensors.
